<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Ginseng Res</journal-id><journal-id journal-id-type="iso-abbrev">J Ginseng Res</journal-id><journal-title-group><journal-title>Journal of Ginseng Research</journal-title></journal-title-group><issn pub-type="ppub">1226-8453</issn><issn pub-type="epub">2093-4947</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31695568</article-id><article-id pub-id-type="pmc">6823735</article-id><article-id pub-id-type="publisher-id">S1226-8453(18)30223-9</article-id><article-id pub-id-type="doi">10.1016/j.jgr.2018.07.009</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Studies of the effects and mechanisms of ginsenoside Re and Rk<sub>3</sub> on myelosuppression induced by cyclophosphamide</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Han</surname><given-names>Jiahong</given-names></name><xref rid="fn1" ref-type="fn">&#x02606;</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Xia</surname><given-names>Jing</given-names></name><xref rid="fn1" ref-type="fn">&#x02606;</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Zhang</surname><given-names>Lianxue</given-names></name><email>zhanglianxue126621@126.com</email><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Cai</surname><given-names>Enbo</given-names></name><xref rid="cor2" ref-type="corresp">&#x02217;&#x02217;</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Zhao</surname><given-names>Yan</given-names></name></contrib><contrib contrib-type="author" id="au6"><name><surname>Fei</surname><given-names>Xuan</given-names></name></contrib><contrib contrib-type="author" id="au7"><name><surname>Jia</surname><given-names>Xiaohuan</given-names></name></contrib><contrib contrib-type="author" id="au8"><name><surname>Yang</surname><given-names>He</given-names></name></contrib><contrib contrib-type="author" id="au9"><name><surname>Liu</surname><given-names>Shuangli</given-names></name></contrib></contrib-group><aff id="aff1">College of Chinese Medicinal Material, Jilin Agricultural University, Changchun, China</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. College of Chinese Medicinal Material, Jilin Agricultural University, 2888 Xincheng Street, Changchun, Jilin province, 130118, China. <email>zhanglianxue126621@126.com</email></corresp><corresp id="cor2"><label>&#x02217;&#x02217;</label>Corresponding author. College of Chinese Medicinal Material, Jilin Agricultural University, Xincheng Street No. 2888, Changchun, Jilin province, 130118, China.</corresp><fn id="fn1"><label>&#x02606;</label><p id="ntpara0010">Jiahong Han and Jing Xia contributed equally to this work.</p></fn></author-notes><pub-date pub-type="pmc-release"><day>30</day><month>8</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>10</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>8</month><year>2018</year></pub-date><volume>43</volume><issue>4</issue><fpage>618</fpage><lpage>624</lpage><history><date date-type="received"><day>21</day><month>6</month><year>2018</year></date><date date-type="accepted"><day>30</day><month>7</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 The Korean Society of Ginseng, Published by Elsevier Korea LLC.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder/><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><sec><title>Background</title><p>Ginsenoside Re (Re) is one of the major components of <italic>Panax ginseng</italic> Meyer. Ginsenoside Rk<sub>3</sub> (Rk<sub>3</sub>) is a secondary metabolite of Re. The aim of this study was to investigate and compare the effects and underlying mechanisms of Re and Rk<sub>3</sub> on cyclophosphamide-induced myelosuppression.</p></sec><sec><title>Methods</title><p>The mice myelosuppression model was established by intraperitoneal (i.p.) injection of cyclophosphamide. Peripheral blood cells, bone marrow nucleated cells, and colony yield of hematopoietic progenitor cells <italic>in&#x000a0;vitro</italic> were counted. The levels of erythropoietin, thrombopoietin, and granulocyte macrophage colony-stimulating factor in plasma were measured by enzyme-linked immunosorbent assay. Bone marrow cell cycle was performed by flow cytometry. The expression of apoptotic protein bcl-2, bax, and caspase-3 was detected by Western blotting.</p></sec><sec><title>Results</title><p>Both Re and Rk<sub>3</sub> could improve peripheral blood cells, bone marrow nucleated cell counts, thymus index, and spleen index. Furthermore, they could enhance the yield of colonies cultured <italic>in&#x000a0;vitro</italic> and make the levels of granulocyte macrophage colony-stimulating factor, erythropoietin, and thrombopoietin normal, reduce the ratio of G<sub>0</sub>/G<sub>1</sub> phase cells, and increase the proliferation index. Finally, Re and Rk<sub>3</sub> could upregulate the expression of bcl-2, whereas they could downregulate the expression of bax and caspase-3.</p></sec><sec><title>Conclusion</title><p>Re and Rk<sub>3</sub> could improve the hematopoietic function of myelosuppressed mice. The effect of Rk<sub>3</sub> was superior to that of Re at any dose. Regulating the levels of cytokines, promoting cells enter the normal cell cycle, regulating the balance of bcl-2/bax, and inhibiting the expression of caspase-3 may be the effects of Re and Rk<sub>3</sub> on myelosuppression.</p></sec></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Chemotherapy</kwd><kwd>Ginsenoside Re</kwd><kwd>Ginsenoside Rk<sub>3</sub></kwd><kwd>Myelosuppression</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p id="p0010">Cancer has emerged as a serious global threat. Chemotherapy is one of the most effective treatments for cancer. It is a systemic treatment, but at the same time, it often causes myelosuppression due to its toxicity to cells. Myelosuppression often first manifests as a decline in white blood cells, followed by a series of hematopoietic impairments <xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>. Its essence is the decrease of precursor blood cell activity, which affects the ability of hematopoietic stem cells to proliferate and differentiate <xref rid="bib3" ref-type="bibr">[3]</xref>, <xref rid="bib4" ref-type="bibr">[4]</xref>. Myelosuppression can limit the progress of chemotherapy; severe myelosuppression also leads to secondary infections or bleeding, which in turn threatens the lives of patients <xref rid="bib5" ref-type="bibr">[5]</xref>, <xref rid="bib6" ref-type="bibr">[6]</xref> Therefore, improving the symptoms of myelosuppression during the treatment of cancer has become the key to ensure the efficacy of chemotherapy.</p><p id="p0015">Ginseng is the root of <italic>Panax ginseng</italic> Meyer. It has been used as a traditional Chinese medicine in China for more than 4,000 years. Total ginsenosides derived from ginseng possess various biological activities <xref rid="bib7" ref-type="bibr">[7]</xref>. Among the total ginsenosides, ginsenoside Re (Re) is regarded as the main active components. Modern medical research shows that Re plays an important role in resisting cancer <xref rid="bib8" ref-type="bibr">[8]</xref>, improving immunity <xref rid="bib9" ref-type="bibr">[9]</xref>, enhancing memory <xref rid="bib10" ref-type="bibr">[10]</xref>, and improving cardiovascular system <xref rid="bib11" ref-type="bibr">[11]</xref>. Ginsenoside Rk<sub>3</sub> (Rk<sub>3</sub>) is a secondary metabolite of Re. Previous experiments showed that Rk<sub>3</sub> possesses anticancer <xref rid="bib12" ref-type="bibr">[12]</xref>, immunomodulatory <xref rid="bib13" ref-type="bibr">[13]</xref>, and anti&#x02013;platelet-aggregating <xref rid="bib14" ref-type="bibr">[14]</xref> activities. Re is a kind of polar ginsenoside, whereas Rk<sub>3</sub> is a kind of nonpolar ginsenoside. Rk<sub>3</sub> can be obtained from Re by hydrolysis of the sugar moieties <xref rid="bib15" ref-type="bibr">[15]</xref>. Compared with polar ginsenosides, nonpolar ginsenosides are more easily absorbed and have better pharmacological activity due to its lower polarity <xref rid="bib15" ref-type="bibr">[15]</xref>.</p><p id="p0020">Based on the traditional efficacy of ginseng and previous studies, we speculated that Re and Rk<sub>3</sub> can improve bone marrow hematopoietic function and can be used for the treatment of chemotherapy-induced myelosuppression. To validate the speculation and compare the two, we investigated the effects of Re and Rk<sub>3</sub> on hematopoietic function of bone marrow, including peripheral blood, bone marrow nucleated cell (BMNC) counts, and thymus/spleen index in cyclophosphamide (CTX)-induced myelosuppression mice. The mechanism of action is explored at the cellular and molecular levels&#x000a0;by detecting the proliferation and differentiation of hematopoietic progenitor cells, bone marrow cell cycle, cell growth factor content, and bone marrow cell apoptosis protein expression.</p></sec><sec id="sec2"><label>2</label><title>Materials and methods</title><sec id="sec2.1"><label>2.1</label><title>Materials</title><p id="p0025">Re and Rk<sub>3</sub> were purchased from College of Fundamental Medical, Jilin University (Changchun, China). All standards were at least 98% pure, as confirmed by HPLC. HPLC-grade acetonitrile and methanol were purchased from Fisher (USA). Cyclophosphamide was obtained from Jiangsu Shengdi Pharmaceutical Co., Ltd. (Lianyungang, Jiangsu, China). Mouse G-CSF, erythropoietin (EPO), thrombopoietin (TPO), and interleukin-2 (IL-2) were supplied by novoprotein Scientific Inc. (Shanghai, China). We purchased enzyme-linked immunosorbent assay kits for mouse G-CSF, EPO, and TPO from R&#x00026;D systems (Minneapolis, MN, USA). Rabbit monoclonal anti-bax, anti-bcl-2, and anti-caspase-3 antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). Propidium iodide used in current experiments was purchased from Tianjin Sungene Biotech Co., Ltd. (Tianjin, China). All other chemicals were of the highest grade from a commercial source.</p></sec><sec id="sec2.2"><label>2.2</label><title>Animals</title><p id="p0030">Male Balb/c mice with body weights ranging from 18 to 22&#x000a0;g were obtained from the Laboratory Animal Quality Testing Center of Jilin Province (Certificate No. SCXK-2016-0003) and maintained at controlled temperature (22&#x000a0;&#x000b1;&#x000a0;2&#x000b0;C) and humidity (50%&#x000a0;&#x000b1;&#x000a0;10%) with a 12&#x000a0;h/12&#x000a0;h light/dark cycle. All efforts were made to minimize the pain of animals. The animal procedures were performed in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals and approved by the Animal Ethics Committee of China Academy of Chinese Medical Sciences.</p><p id="p0035">After seven days of acclimatization, the mice were divided into seven groups (n&#x000a0;=&#x000a0;10 per group): (1) normal control group (Normal), (2) CTX treatment group (Model), (3) CTX&#x000a0;+&#x000a0;rhG-CSF (Positive), (4) CTX&#x000a0;+&#x000a0;low-dose Re (Re-L), (5) CTX&#x000a0;+&#x000a0;high-dose Re (Re-H), (6) CTX&#x000a0;+&#x000a0;low-dose Rk<sub>3</sub> (Rk<sub>3</sub>-L), and (7) CTX&#x000a0;+&#x000a0;high-dose Rk<sub>3</sub> (Rk<sub>3</sub>-H).</p><p id="p0040">The mice in Groups 2&#x02013;7 were intraperitoneally (i.p.) injected with a dose of CTX (100&#x000a0;mg&#x000a0;kg<sup>&#x02212;1</sup>, 0.1&#x000a0;mL&#x000a0;10&#x000a0;g<sup>&#x02212;1</sup>) for 3 days, and the normal group received an equal volume of saline. After CTX treatment for 24 hours, all the drug treatment groups (Groups 3&#x02013;7) were i.p.&#x000a0;injected with rhG-CSF (11.25&#x000a0;&#x003bc;g&#x000a0;kg<sup>&#x02212;1</sup>), Re (5 and 10&#x000a0;mg&#x000a0;kg<sup>&#x02212;1</sup>), or Rk<sub>3</sub> (5 and 10&#x000a0;mg&#x000a0;kg<sup>&#x02212;1</sup>) for 7 days. The normal and model groups were administered an equivalent volume of saline water, once a day for 7 consecutive days.</p></sec><sec id="sec2.3"><label>2.3</label><title>Detection of peripheral blood cells</title><p id="p0045">On Day 11, blood samples were collected from the eye socket vein, and white blood cells (WBCs), red blood cells (RBCs), hemoglobin (HGB), and platelets (PLTs) were counted using a cell counter. After the last drug administration, body weights of mice were measured. Blood samples were extracted from eyeballs and collected in&#x000a0;test tubes with ethylenediaminetetraacetic acid for further analysis.</p></sec><sec id="sec2.4"><label>2.4</label><title>Determinations of thymus/spleen index and bone marrow nucleated cells</title><p id="p0050">After blood samples were collected, mice were euthanized by cervical vertebra dislocation and then placed in 75% ethanol for 5&#x000a0;min twice. Immediately, the thymus gland and spleen were excised and weighed, and the thymus and spleen indices were calculated as the thymus weight/body weight and spleen weight/body weight, respectively.</p><p id="p0055">Double femurs were removed under aseptic conditions, and bone marrow cells were flushed using sterile phosphate-buffered saline (PBS) to form a single cell suspension. The suspension was taken in a centrifuge tube&#x000a0;and centrifuged for 10&#x000a0;min at 1200r/min. And, 2&#x000a0;mL of RBC lysis buffer was added, and it was let to stand for 3 minutes after blending&#x000a0;centrifuged for 10&#x000a0;min at 1200r/min. The bone marrow karyocytes were removed and rinsed twice with 1&#x000a0;mL of sterile PBS for 10&#x000a0;min at 1200r/min and then resuspended in sterile PBS and counted using an inverted microscope.</p></sec><sec id="sec2.5"><label>2.5</label><title>Hematopoietic progenitor cells culture</title><p id="p0060">Bone marrow cells were plated at a concentration of 10<sup>5</sup>/mL on Iscove's Modified Dulbecco's Medium (IMDM) medium supplemented with horse serum, 10<sup>&#x02212;4</sup>M 2-mercaptoethanol, 2&#x000a0;mM 3% L-glutamine, 20&#x000a0;ng/mL of recombinant mouse (rm) IL-3, 20&#x000a0;U/mL of recombinant human (rh) EPO, 50&#x000a0;ng/mL of rm granulocyte macrophage colony-stimulating factor (GM-CSF), and 5&#x000a0;ng/mL of rm TPO.</p><p id="p0065">Plates were cultured at 37&#x000b0;C in 5% CO<sub>2</sub> atmosphere. Colony-forming unit erythroid (CFU-E) were counted under inverted phase-contrast microscope after 3 days of culture. Burst-forming unit erythroid (BFU-E), colony-forming unit granulocyte macrophage&#x000a0;(CFU-GM), and colony-forming unit megakaryocte (CFU-Meg) were counted after 7 days of culture.</p></sec><sec id="sec2.6"><label>2.6</label><title>Determination of the levels of GM-CSF, EPO, and TPO in plasma</title><p id="p0070">Plasma samples were prepared from the blood samples collected from the mice, and the levels of EPO, TPO, GM-CSF, and IL-6 were measured by enzyme-linked immunosorbent assay.</p></sec><sec id="sec2.7"><label>2.7</label><title>Cell cycle</title><p id="p0075">A single cell suspension was collected in&#x000a0;a centrifuge tube, rinsed twice with cold PBS, and centrifuged, and then, 2&#x000a0;mL of 70% cold ethanol was added to fix the cells overnight at 4&#x000b0;C. Cells were then incubated with in the dark for 30&#x000a0;min. Cells from all groups were measured by flow cytometry.</p></sec><sec id="sec2.8"><label>2.8</label><title>Analysis of protein expressions of bal-2, bax, and caspase-3 in bone marrow cells</title><p id="p0080">Western blotting is used for the determination of protein content. Total protein in BMNC was extracted, and protein concentration was determined by Bradford method. Protein samples were denatured and separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) electrophoresis, transferred to Poly(vinylidene fluoride) (PVDF) membrane by semi-dry electrophoresis, and blocked using 5% skimmed milk liquid for 1&#x000a0;h, and primary antibodies were added and left undisturbed at 4&#x000b0;C overnight. After adding a secondary antibody (1:3000) and incubating for 1 hour, the color was developed by chemiluminescence. &#x003b2;-Actin was used as an internal reference. After the film was scanned, the protein bands were quantitatively analyzed, and the gray ratios of the target protein band and &#x003b2;-actin band were calculated as the relative expression level of each target protein.</p></sec><sec id="sec2.9"><label>2.9</label><title>Statistical analysis</title><p id="p0085">The data were expressed as mean&#x000a0;&#x000b1;&#x000a0;standard deviation. Statistical analysis was performed by one-way analysis of variance. Statistical analysis was performed using SPSS version 13.0 (SPSS, Chicago, IL, USA) statistical software, and <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 was considered statistically significant.</p></sec></sec><sec id="sec3"><label>3</label><title>Results</title><sec id="sec3.1"><label>3.1</label><title>Effect of Re and Rk<sub>3</sub> on peripheral blood cells in CTX-induced mice</title><p id="p0090">The quantities of WBC, RBC, HGB, and PLT from peripheral blood are shown in <xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>. Compared with normal mice, the quantity of WBC increased (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01), whereas RBC, HGB, and PLT decreased significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01) in the model group with CTX at a dose of 100&#x000a0;mg/kg. It also indicates that both Re and Rk<sub>3</sub> can increase the quantities of HGB and PLT and decrease the quantity of WBC, whereas only Rk<sub>3</sub>-H can increase the quantity of RBC significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05). Two high-dose groups are more effective than two low-dose groups, and Rk<sub>3</sub> is more effective than Re at any dose group.<table-wrap position="float" id="tbl1"><label>Table&#x000a0;1</label><caption><p>Effect of Re and Rk<sub>3</sub> on peripheral blood cells in CTX-induced mice</p></caption><alt-text id="alttext0035">Table&#x000a0;1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Groups</th><th>WBC (&#x000d7;10<sup>9</sup>/L)</th><th>RBC (&#x000d7;10<sup>12</sup>/L)</th><th>HGB (g/L)</th><th>PLT (&#x000d7;10<sup>9</sup>/L)</th></tr></thead><tbody><tr><td>Normal</td><td>7.30&#x000a0;&#x000b1;&#x000a0;0.75</td><td>9.76&#x000a0;&#x000b1;&#x000a0;0.27</td><td>131.00&#x000a0;&#x000b1;&#x000a0;4.59</td><td>917.10&#x000a0;&#x000b1;&#x000a0;74.65</td></tr><tr><td>Model</td><td>10.34&#x000a0;&#x000b1;&#x000a0;1.40<sup>##</sup></td><td>8.63&#x000a0;&#x000b1;&#x000a0;0.68<sup>##</sup></td><td>113.20&#x000a0;&#x000b1;&#x000a0;6.66<sup>##</sup></td><td>628.50&#x000a0;&#x000b1;&#x000a0;66.09<sup>##</sup></td></tr><tr><td>Positive</td><td>8.47&#x000a0;&#x000b1;&#x000a0;0.87<sup>&#x02217;&#x02217;</sup></td><td>9.46&#x000a0;&#x000b1;&#x000a0;0.41<sup>&#x02217;&#x02217;</sup></td><td>126.70&#x000a0;&#x000b1;&#x000a0;5.70<sup>&#x02217;&#x02217;</sup></td><td>881.10&#x000a0;&#x000b1;&#x000a0;76.87<sup>&#x02217;&#x02217;</sup></td></tr><tr><td>Re-L</td><td>9.40&#x000a0;&#x000b1;&#x000a0;1.28</td><td>8.80&#x000a0;&#x000b1;&#x000a0;0.58</td><td>118.90&#x000a0;&#x000b1;&#x000a0;8.67</td><td>790.00&#x000a0;&#x000b1;&#x000a0;97.66<sup>&#x02217;&#x02217;</sup></td></tr><tr><td>Re-H</td><td>8.81&#x000a0;&#x000b1;&#x000a0;0.89<sup>&#x02217;&#x02217;</sup></td><td>8.95&#x000a0;&#x000b1;&#x000a0;0.75</td><td>121.10&#x000a0;&#x000b1;&#x000a0;6.31<sup>&#x02217;&#x02217;</sup></td><td>833.10&#x000a0;&#x000b1;&#x000a0;68.04<sup>&#x02217;&#x02217;</sup></td></tr><tr><td>Rk<sub>3</sub>-L</td><td>9.2&#x000a0;&#x000b1;&#x000a0;1.29<sup>&#x02217;</sup></td><td>8.85&#x000a0;&#x000b1;&#x000a0;1.02</td><td>122.00&#x000a0;&#x000b1;&#x000a0;5.29<sup>&#x02217;&#x02217;</sup></td><td>799.90&#x000a0;&#x000b1;&#x000a0;72.21<sup>&#x02217;&#x02217;</sup></td></tr><tr><td>Rk<sub>3</sub>-H</td><td>8.51&#x000a0;&#x000b1;&#x000a0;0.97<sup>&#x02217;&#x02217;</sup></td><td>9.25&#x000a0;&#x000b1;&#x000a0;0.59<sup>&#x02217;</sup></td><td>127.40&#x000a0;&#x000b1;&#x000a0;3.92<sup>&#x02217;&#x02217;a</sup></td><td>853.60&#x000a0;&#x000b1;&#x000a0;76.65<sup>&#x02217;&#x02217;</sup></td></tr></tbody></table><table-wrap-foot><fn id="tspara0015"><p>Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD (n&#x000a0;=&#x000a0;10)</p></fn><fn id="tspara0020"><p><sup>##</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the normal group. <sup>&#x02217;&#x02217;</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the model group. *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 as compared with the model group. <sup>a</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 as compared with the Re-H group</p></fn><fn id="tspara0025"><p>CTX, cyclophosphamide; HGB, hemoglobin; PLT, platelet; RBC, red blood cell; SD, standard deviation; WBC, white blood cell</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec3.2"><label>3.2</label><title>Effect of Re and Rk<sub>3</sub> on the thymus/spleen index in CTX-induced mice</title><p id="p0095">As shown in <xref rid="tbl2" ref-type="table">Table&#x000a0;2</xref>, compared with the normal group, the thymus index and spleen index of the mice in the model group changed significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01). The thymus index showed a decrease, and the spleen index is opposite to thymus index. Re and Rk<sub>3</sub> can increase the thymus index significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01) while reduce the spleen index, but the effect on the spleen is not significant.<table-wrap position="float" id="tbl2"><label>Table&#x000a0;2</label><caption><p>Effects of Re and Rk<sub>3</sub> on the thymus/spleen index in CTX-induced mice</p></caption><alt-text id="alttext0040">Table&#x000a0;2</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Groups</th><th>Thymus index (mg/g)</th><th>Spleen index (mg/g)</th></tr></thead><tbody><tr><td>Normal</td><td>1.14&#x000a0;&#x000b1;&#x000a0;0.14</td><td>4.02&#x000a0;&#x000b1;&#x000a0;0.38</td></tr><tr><td>Model</td><td>0.28&#x000a0;&#x000b1;&#x000a0;0.05<sup>##</sup></td><td>8.94&#x000a0;&#x000b1;&#x000a0;1.10<sup>##</sup></td></tr><tr><td>Positive</td><td>0.60&#x000a0;&#x000b1;&#x000a0;0.08<sup>&#x02217;&#x02217;</sup></td><td>8.23&#x000a0;&#x000b1;&#x000a0;1.36</td></tr><tr><td>Re-L</td><td>0.49&#x000a0;&#x000b1;&#x000a0;0.06<sup>&#x02217;&#x02217;</sup></td><td>8.70&#x000a0;&#x000b1;&#x000a0;0.86</td></tr><tr><td>Re-H</td><td>0.57&#x000a0;&#x000b1;&#x000a0;0.07<sup>&#x02217;&#x02217;</sup></td><td>8.55&#x000a0;&#x000b1;&#x000a0;0.96</td></tr><tr><td>Rk<sub>3</sub>-L</td><td>0.52&#x000a0;&#x000b1;&#x000a0;0.07<sup>&#x02217;&#x02217;</sup></td><td>8.60&#x000a0;&#x000b1;&#x000a0;1.64</td></tr><tr><td>Rk<sub>3</sub>-H</td><td>0.65&#x000a0;&#x000b1;&#x000a0;0.09<sup>&#x02217;&#x02217;a</sup></td><td>8.25&#x000a0;&#x000b1;&#x000a0;0.67</td></tr></tbody></table><table-wrap-foot><fn id="tspara0035"><p>Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD (n&#x000a0;=&#x000a0;10)</p></fn><fn id="tspara0040"><p><sup>##</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the normal group. <sup>&#x02217;&#x02217;</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the model group. <sup>a</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 as compared with the Re-H group</p></fn><fn id="tspara0045"><p>CTX, cyclophosphamide; SD, standard deviation</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec3.3"><label>3.3</label><title>Effect of Re and Rk<sub>3</sub> on the BMNC counts in CTX-induced mice</title><p id="p0100">The quantity of BMNC was shown in <xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>. Compared with the mice in the normal group, the quantity of BMNC decreased significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01) in the model group. Both Re and Rk<sub>3</sub> can increase the quantity of BMNC significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01) no matter high dose or low dose. We can also indicate that Rk<sub>3</sub>-H showed significant effects compared with the other three groups (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05).<fig id="fig1"><label>Fig.&#x000a0;1</label><caption><p>Effect of Re and Rk<sub>3</sub> on the BMNC count in CTX-induced mice. Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD (n&#x000a0;=&#x000a0;6). <sup>##</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the normal group. <sup>&#x02217;&#x02217;</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the model group. <sup>a</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 as compared with the Re-H group.</p><p>BMNC, bone marrow nucleated cell; CTX, cyclophosphamide; SD, standard deviation.</p></caption><alt-text id="alttext0010">Fig.&#x000a0;1</alt-text><graphic xlink:href="gr1"/></fig></p></sec><sec id="sec3.4"><label>3.4</label><title>Effect of Re and Rk<sub>3</sub> on colony yield of hematopoietic progenitor cells <italic>in&#x000a0;vitro</italic> in CTX-induced mice</title><p id="p0105">The yields of colony cultured <italic>in&#x000a0;vitro</italic> were shown in <xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>. Compared with the mice in the normal group, the yields of CFU-GM, CFU-E, BFU-E, and CFU-Meg decreased significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01) in the model group. Rk<sub>3</sub>-H and Re-H can increase the yields significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 or <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05), whereas the effect of Rk<sub>3</sub>-L and Re-L on colony is not significant.<fig id="fig2"><label>Fig.&#x000a0;2</label><caption><p>Effect of Re and Rk<sub>3</sub> on colony yield of hematopoietic progenitor cells <italic>in&#x000a0;vitro</italic> in CTX-induced mice. Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD (n&#x000a0;=&#x000a0;6). <sup>##</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the normal group.<sup>&#x02217;</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 as compared with the model group. <sup>&#x02217;&#x02217;</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the model group. <sup>a</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 as compared with the Re-H group.</p><p>BFU-E, Burst-forming unit erythroid; CFU-E, Colony-forming unit erythroid; CFU-GM, colony-forming unit granulocyte macrophage; CFU-Meg, colony-forming unit megakaryocte; CTX, cyclophosphamide; SD, standard deviation.</p></caption><alt-text id="alttext0015">Fig.&#x000a0;2</alt-text><graphic xlink:href="gr2"/></fig></p></sec><sec id="sec3.5"><label>3.5</label><title>Effect of Re and Rk<sub>3</sub> on the hematopoiesis-related cytokines in CTX-induced mice</title><p id="p0110">As shown in <xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>, compared to the normal group, the level of GM-CSF and TPO in the model group increased significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01). Both Rk<sub>3</sub>-H and Re-H can decrease the level of TPO significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 or <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05). Only Rk<sub>3</sub>-H can decrease the level of GM-CSF significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01).The differences between these 7 groups on the level of EPO are all not significantly.<fig id="fig3"><label>Fig.&#x000a0;3</label><caption><p>Effect of Re and Rk<sub>3</sub> on the hematopoiesis-related cytokines (A) GM-CSF, (B) EPO, and (C) TPO in CTX-induced mice. Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD (n&#x000a0;=&#x000a0;10). <sup>##</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the normal group.<sup>&#x02217;</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 as compared with the model group. <sup>&#x02217;&#x02217;</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the model group. <sup>a</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 as compared with the Re-H group.</p><p>CTX, cyclophosphamide; EPO, erythropoietin; GM-CSF, granulocyte macrophage colony-stimulating factor; SD, standard deviation; TPO, thrombopoietin.</p></caption><alt-text id="alttext0020">Fig.&#x000a0;3</alt-text><graphic xlink:href="gr3"/></fig></p></sec><sec id="sec3.6"><label>3.6</label><title>Effect of Re and Rk<sub>3</sub> on cell cycle in CTX-induced mice</title><p id="p0115">The ratios of every phase were shown in <xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>. The ratio of G<sub>0</sub>/G<sub>1</sub> phase in the model group was significantly higher than that in the normal group (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01). At the same time, the ratios of S phase and G<sub>2</sub>/M phase are significantly lower (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01). Both Re and Rk<sub>3</sub> can decrease the ratio of G<sub>0</sub>/G<sub>1</sub> phase and increase the ratios of S phase significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 or <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05). Only Rk<sub>3</sub>-H can increase the ratios of G<sub>2</sub>/M phase significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05).<fig id="fig4"><label>Fig.&#x000a0;4</label><caption><p>Effect of Re and Rk<sub>3</sub> on cell cycle in CTX-induced mice. Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD (n&#x000a0;=&#x000a0;6). <sup>##</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the normal group. <sup>&#x02217;</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 as compared with the model group. <sup>&#x02217;&#x02217;</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the model group.</p><p>CTX, cyclophosphamide; SD, standard deviation.</p></caption><alt-text id="alttext0025">Fig.&#x000a0;4</alt-text><graphic xlink:href="gr4"/></fig></p></sec><sec id="sec3.7"><label>3.7</label><title>Effect of Re and Rk<sub>3</sub> on protein expressions of bcl-2, bax, and caspase-3 in bone marrow cell in CTX-induced mice</title><p id="p0120">The expressions of bcl-2, bax, and caspase-3 were shown in <xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref>. Compared with the normal group, the expression of bcl-2 decreased significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05), whereas the expression of bax and caspase-3 increased significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) in the bone marrow cells of the mice from the model group. Both Re and Rk<sub>3</sub> can increase the expression of bcl-2 and decrease the expression of bax and caspase-3 significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 or <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05). The effect of Rk<sub>3</sub> is better than Re significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) on bcl-2 and bax while not significantly on caspase-3.<fig id="fig5"><label>Fig.&#x000a0;5</label><caption><p>Effect of Re and Rk<sub>3</sub> on protein expressions of (A) bcl-2, (B) bax, (C) bcl-2/bax, and (D) caspase-3 in bone marrow cell in CTX-induced mice. Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD (n&#x000a0;=&#x000a0;3). <sup>##</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the normal group. <sup>&#x02217;&#x02217;</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 as compared with the model group. <sup>a</sup><italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 as compared with the Re-H group.</p><p>CTX, cyclophosphamide; SD, standard deviation.</p></caption><alt-text id="alttext0030">Fig.&#x000a0;5</alt-text><graphic xlink:href="gr5"/></fig></p></sec></sec><sec id="sec4"><label>4</label><title>Discussion</title><p id="p0125">CTX&#x000a0;is one of the most commonly used alkylating cytotoxic chemotherapeutic agents <xref rid="bib16" ref-type="bibr">[16]</xref>. It can directly damage intracellular DNA molecules <xref rid="bib17" ref-type="bibr">[17]</xref>, affect cell division, and can also induce senescence and apoptosis of hematopoietic stem cells <xref rid="bib18" ref-type="bibr">[18]</xref>, <xref rid="bib19" ref-type="bibr">[19]</xref>. Owing to the lack of specificity, while killing and damaging tumor cells, CTX also affects the hematopoietic precursor stem cells <xref rid="bib20" ref-type="bibr">[20]</xref>, <xref rid="bib21" ref-type="bibr">[21]</xref>. In this study, the model of mice with myelosuppression was established by i.p. injection of CTX. After injection, as same as the clinical symptoms of myelosuppression, the mice showed signs of reduced diet, weight loss, diarrhea, mass hair loss, and fatigue.</p><p id="p0130">Myelosuppression appears as a decrease in the number of various types of blood cells in the peripheral blood <xref rid="bib22" ref-type="bibr">[22]</xref>. Therefore, the number of WBC, RBC, HGB, and PLT from peripheral blood can directly reflect the degree of myelosuppression. The number of WBC changes most obviously because of its short life cycle <xref rid="bib23" ref-type="bibr">[23]</xref>. The number of WBC in the mice from the model group was significantly higher than that of mice from the normal group. Some cell&#x000a0;stores in bone marrow may be mobilized into the peripheral blood quickly after the WBC death caused by CTX. This should be the rebound of WBC <xref rid="bib24" ref-type="bibr">[24]</xref> because these cells do not have a sound function just like WBC, but only the body's stress response to the loss of WBC. So they have no immune function. WBC will decrease rapidly after rebound which was proved in our preliminary experiments. The increase of WBC in the mice from the administration group was smaller than that from the model group. We speculated that the Re and Rk<sub>3</sub> can improve myelosuppression to a certain extent, which reduces the degree of stress response in WBC. Thrombocytopenia can cause bleeding, while severe reduction can even lead to death. The number of PLT in the mice from the model group was significantly lower than that of mice from the normal group. PLT life cycle may&#x000a0;become shorter because of the damage of megakaryocyte. The number of PLT in mice from the administration group increased. It shows that Re and Rk<sub>3</sub> can promote recovery the bone marrow hematopoietic function.</p><p id="p0135">The number of BMNCs is a direct indicator of bone marrow hematopoietic function <xref rid="bib24" ref-type="bibr">[24]</xref>. The decrease in the number of BMNC in the model group indicates that CTX may cause acute damage of bone marrow and induce senescence and apoptosis of BMNC. The damage is somewhat alleviated after administration. The thymus index and spleen index were also investigated in the present study because of the close relationship between immunity and hematopoiesis <xref rid="bib24" ref-type="bibr">[24]</xref>. The thymus is an important immune organ <xref rid="bib25" ref-type="bibr">[25]</xref>. The maturation of lymphocytes also depends on the thymus <xref rid="bib26" ref-type="bibr">[26]</xref>. Thymus and thymocytes not only provide&#x000a0;a specific microenvironment&#x000a0;but also secrete&#x000a0;important cytokines <xref rid="bib27" ref-type="bibr">[27]</xref>. The thymus index of mice from the model group decreased significantly. The damage of immune organs may be caused by apoptosis of thymocytes due to CTX. The increase of thymus index indicates that the Re and Rk<sub>3</sub> can promote the recovery of this damage after administration. Spleen is not only a hematopoietic organ but also an immune organ <xref rid="bib28" ref-type="bibr">[28]</xref>. The spleen can restore hematopoiesis and perform compensatory extramedullary hematopoiesis when the function of bone marrow is damaged <xref rid="bib29" ref-type="bibr">[29]</xref>. The increase of spleen index in mice from the model group indicates that while CTX causes bone marrow hematopoietic damage in mice, spleen compensatory hematopoiesis leads to spleen connective tissue hyperplasia. The spleen index of the mice from the administration group is smaller than that of the model group. We speculate that Re and Rk<sub>3</sub> may reduce the burden of the spleen while restoring bone marrow hematopoietic function <xref rid="bib30" ref-type="bibr">[30]</xref>.</p><p id="p0140">To further explore the mechanism of Re and Rk<sub>3</sub> in improving hematopoietic function, we analyzed the effect on colony yield of hematopoietic progenitor cells <italic>in&#x000a0;vitro</italic>; the effect on TPO, EPO, and GM-CSF of plasma; and the effect on cell cycle and the expression of bcl-2, bax, and caspase-3 proteins.</p><p id="p0145">The essence of myelosuppression is that the function of hematopoietic stem cell/hematopoietic progenitor cell (HSC/HPC) in the bone marrow is impaired after chemotherapy <xref rid="bib31" ref-type="bibr">[31]</xref>. The yield of colony cultured <italic>in&#x000a0;vitro</italic> can be used to evaluate the function of HSC/HPC. The yield of BFU-E, CFU-E, CFU-Meg, and CFU-GM is lower in the mice from the model group. It showed that CTX can cause serious damage to the proliferation and differentiation of HPC. The yield of colony in the mice from the administration group was more than that in the model group significantly. We speculate that Re and Rk<sub>3</sub> may increase the sensitivity of the receptor on the cell surface that binds to the cytokines and enhance the proliferation and differentiation of HPC. The quantity of bone marrow cells that have been reduced by the damage of CTX is recovered so that the peripheral blood can restore.</p><p id="p0150">Cytokines are important factors to stimulate the proliferation and differentiation of HSC/HPC <xref rid="bib32" ref-type="bibr">[32]</xref>. GM-CSF has stimulative effect of the proliferation and differentiation on the process from myeloid stem cells to mature granulocytes <xref rid="bib33" ref-type="bibr">[33]</xref>. The main physiological function of EPO is promoting the binding of erythroid progenitor cells' surface receptor, acceleration erythroid stem cells differentiate into erythrocytes and synthesis of HGB <xref rid="bib34" ref-type="bibr">[34]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref>. TPO can boost HSC differentiation to megakaryocytes, stimulate the development and maturity of megakaryocytes, and gear up the production and release of PLT <xref rid="bib36" ref-type="bibr">[36]</xref>. When HSC activity weakens, the number of these cytokines will be forced to rise. This is a reflection of the body's compensation mechanism <xref rid="bib37" ref-type="bibr">[37]</xref>. Our results show that both Re and Rk<sub>3</sub> make the number of GM-CSF, EPO, and TPO normal, indirectly demonstrating the recovery of hematopoietic stem cells' proliferative and differentiative capacity.</p><p id="p0155">The cell cycle of bone marrow is one of the important indicators reflecting the hematopoietic function of the hematopoietic system, and the distribution of the various phases of the cell cycle can reflect the state of bone marrow cell proliferation <xref rid="bib38" ref-type="bibr">[38]</xref>. The ratio of G<sub>0</sub>/G<sub>1</sub> phase in the model group was significantly higher than that in the normal group, indicating the CTX-induced DNA damage in hematopoietic cells&#x000a0;and that the damaged DNA stayed in G<sub>1</sub> phase to repair. And, for DNA that cannot be repaired, an apoptotic program will be initiated. This process leads to a reduction in the ratio of cells in the S and G<sub>2</sub>/M phase and the proliferation index. The ratio of G<sub>0</sub>/G<sub>1</sub> phase in the mice in the administration group was significantly lower than that in the model group. We speculate that Re and Rk<sub>3</sub> may facilitate the repair of damaged DNA&#x000a0;and may also arouse part of cells in G<sub>0</sub> phase. Therefore, more cells can pass the G<sub>1</sub> phase checkpoint to enter the S phase for DNA synthesis&#x000a0;and then enter the G<sub>2</sub>/M phase to complete mitosis. Re and Rk<sub>3</sub> can antagonize the toxicity and side effects of CTX on bone marrow cells effectively.</p><p id="p0160">Bcl-2 protein (bcl-2) can inhibit many types of apoptosis. It protects cells by prolonging the survival time of cells so that it can provide time for the repair of DNA that was damaged before cell division <xref rid="bib39" ref-type="bibr">[39]</xref>. Bax protein (bax) has the opposite biological function as bcl-2. Bax can promote apoptosis by increasing the sensitivity of apoptosis <xref rid="bib40" ref-type="bibr">[40]</xref>. Caspase-3 protein (caspase-3) is a common downstream effector of the various apoptosis pathway <xref rid="bib41" ref-type="bibr">[41]</xref>. It is an apoptotic executant that occupies the core position in the whole process of apoptosis <xref rid="bib42" ref-type="bibr">[42]</xref>. It is considered a very specific and sensitive apoptotic marker <xref rid="bib43" ref-type="bibr">[43]</xref>. The results show that Re and Rk<sub>3</sub> can stimulate the expression of bcl-2 and inhibit the expression of bax and caspase-3. Regulating the balance of bcl-2/bax and inhibiting the expression of caspase-3 may be one of the mechanisms of Re and Rk<sub>3</sub> in promoting myeloid bone marrow cell proliferation and recovering bone marrow hematopoietic function in mice.</p></sec><sec id="sec5"><label>5</label><title>Conclusion</title><p id="p0165">In conclusion, the present study demonstrates that Re and Rk<sub>3</sub> could relieve the symptoms of myelosuppression and improve the bone marrow hematopoietic function. It is probably attributed to three different mechanisms. First, Re and Rk<sub>3</sub> could regulate the level of cytokines to normal. Second, Re and Rk<sub>3</sub> could promote more cells to pass the G<sub>1</sub> phase checkpoint to enter the normal cell cycle. Third, Re and Rk<sub>3</sub> could regulate the balance of bcl-2/bax and inhibit the expression of caspase-3 to prevent BMNC from apoptosis. Our results showed that Rk<sub>3</sub> in both low and high concentrations was significantly effective compared with Re. It may be due to its lower polarity, greater lipid solubility, and ease to pass through biofilms. The present study provided an experimental basis for the treatment of myelosuppression and the development of Re and Rk<sub>3</sub>. Furthermore, more precise mechanisms will be investigated in the subsequent research.</p></sec><sec id="sec6"><title>Conflicts of interest</title><p id="p0170">All the authors declare that there are no conflicts of interest.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Hoekman</surname><given-names>K.</given-names></name><name><surname>Wagstaff</surname><given-names>J.</given-names></name><name><surname>van Groeningen</surname><given-names>C.J.</given-names></name><name><surname>Vermorken</surname><given-names>J.B.</given-names></name><name><surname>Boven</surname><given-names>E.</given-names></name><name><surname>Pinedo</surname><given-names>H.M.</given-names></name></person-group><article-title>Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer</article-title><source>J&#x000a0;Natl Cancer Inst</source><volume>83</volume><issue>21</issue><year>1991</year><fpage>1546</fpage><lpage>1553</lpage><pub-id pub-id-type="pmid">1960751</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Molyneux</surname><given-names>G.</given-names></name><name><surname>Andrews</surname><given-names>M.</given-names></name><name><surname>Sones</surname><given-names>W.</given-names></name><name><surname>York</surname><given-names>M.</given-names></name><name><surname>Barnett</surname><given-names>A.</given-names></name><name><surname>Quirk</surname><given-names>E.</given-names></name><name><surname>Yeung</surname><given-names>W.</given-names></name><name><surname>Turton</surname><given-names>J.</given-names></name></person-group><article-title>Haemotoxicity of busulphan, doxorubicin, cisplatin and cyclophosphamide in the female BALB/c mouse using a brief regimen of drug administration</article-title><source>Cell Biol Toxicol</source><volume>27</volume><issue>1</issue><year>2011</year><fpage>13</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">20589437</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Toussaint</surname><given-names>O.</given-names></name><name><surname>Medrano</surname><given-names>E.E.</given-names></name><name><surname>Von</surname><given-names>Z.T.</given-names></name></person-group><article-title>Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes</article-title><source>Exp Gerontol</source><volume>35</volume><issue>8</issue><year>2000</year><fpage>927</fpage><lpage>945</lpage><pub-id pub-id-type="pmid">11121681</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Wickremasinghe</surname><given-names>R.G.</given-names></name><name><surname>Hoffbrand</surname><given-names>A.V.</given-names></name></person-group><article-title>Biochemical and genetic control of apoptosis: relevance to normal hematopoiesis and hematological malignancies</article-title><source>Blood</source><volume>93</volume><issue>11</issue><year>1999</year><fpage>3587</fpage><lpage>3600</lpage><pub-id pub-id-type="pmid">10339463</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Friberg</surname><given-names>L.E.</given-names></name><name><surname>Karlsson</surname><given-names>M.O.</given-names></name></person-group><article-title>Mechanistic models for myelosuppression</article-title><source>Invest New Drugs</source><volume>21</volume><issue>2</issue><year>2003</year><fpage>183</fpage><pub-id pub-id-type="pmid">12889739</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>E.</given-names></name><name><surname>Hu</surname><given-names>S.</given-names></name><name><surname>Concha</surname><given-names>C.</given-names></name></person-group><article-title>Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants</article-title><source>Vaccine</source><volume>21</volume><issue>11</issue><year>2003</year><fpage>1149</fpage><lpage>1157</lpage><pub-id pub-id-type="pmid">12559792</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>L.P.</given-names></name></person-group><article-title>Ginsenosides chemistry, biosynthesis, analysis, and potentialhealth effects</article-title><source>Adv Food Nutr Res</source><volume>55</volume><year>2009</year><fpage>1</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">18772102</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Yamabe</surname><given-names>N.</given-names></name><name><surname>Kim</surname><given-names>Y.J.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Cho</surname><given-names>E.J.</given-names></name><name><surname>Park</surname><given-names>S.H.</given-names></name><name><surname>Ham</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>H.Y.</given-names></name><name><surname>Kang</surname><given-names>K.S.</given-names></name></person-group><article-title>Increase in antioxidant and anticancer effects of ginsenoside Re-lysine mixture by Maillard reaction</article-title><source>Food Chem</source><volume>138</volume><issue>2&#x02013;3</issue><year>2013</year><fpage>876</fpage><lpage>883</lpage><pub-id pub-id-type="pmid">23411191</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Su</surname><given-names>F.</given-names></name><name><surname>Yuan</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Hu</surname><given-names>S.</given-names></name></person-group><article-title>Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway</article-title><source>Vaccine</source><volume>30</volume><issue>27</issue><year>2012</year><fpage>4106</fpage><lpage>4112</lpage><pub-id pub-id-type="pmid">22472794</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Sun</surname><given-names>C.</given-names></name></person-group><article-title>Simultaneous determination of ginsenoside (G-Re, G-Rg<sub>1</sub>, G-Rg<sub>2</sub>, G-F<sub>1</sub>, G-Rh<sub>1</sub>) and protopanaxatriol in human plasma and urine by LC-MS/MS and its application in a pharmacokinetics study of G-Re in volunteers</article-title><source>J&#x000a0;Chromatogr B</source><volume>879</volume><issue>22</issue><year>2011</year><fpage>2011</fpage><lpage>2017</lpage></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name><name><surname>Xie</surname><given-names>L.H.</given-names></name><name><surname>Wicks</surname><given-names>S.M.</given-names></name><name><surname>Xie</surname><given-names>J.T.</given-names></name></person-group><article-title>Ginsenoside Re: pharmacological effects on cardiovascular system</article-title><source>Cardiovasc Therapeut</source><volume>30</volume><issue>4</issue><year>2012</year><fpage>e183</fpage><lpage>e188</lpage></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>Z.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Fan</surname><given-names>D.</given-names></name></person-group><article-title>Anticancer effects of ginsenoside Rk3 on non-small cell lung cancer cells: in&#x000a0;vitro and in&#x000a0;vivo</article-title><source>Food Funct</source><volume>8</volume><issue>10</issue><year>2017</year></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.G.</given-names></name><name><surname>Baek</surname><given-names>S.H.</given-names></name><name><surname>Lee</surname><given-names>Y.Y.</given-names></name><name><surname>Park</surname><given-names>S.Y.</given-names></name><name><surname>Park</surname><given-names>J.H.</given-names></name></person-group><article-title>Anticomplementaryginsenosides isolated from processed ginseng</article-title><source>Biol Pharmaceut Bulletin</source><volume>34</volume><issue>6</issue><year>2011</year><fpage>898</fpage><lpage>900</lpage></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.G.</given-names></name><name><surname>Lee</surname><given-names>Y.Y.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>Y.J.</given-names></name><name><surname>Yun-Choi</surname><given-names>H.S.</given-names></name><name><surname>Park</surname><given-names>J.H.</given-names></name></person-group><article-title>Inhibitory activity of ginsenosides isolated from processed ginseng on platelet aggregation</article-title><source>Pharmazie</source><volume>65</volume><issue>7</issue><year>2010</year><fpage>520</fpage><lpage>522</lpage><pub-id pub-id-type="pmid">20662322</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>J.Q.</given-names></name><name><surname>Ruan</surname><given-names>C.C.</given-names></name><name><surname>Sun</surname><given-names>G.Z.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name></person-group><article-title>Preparation of rare ginsenoside by transformation of ginsenoside Re catalyzed with aspartic acid</article-title><source>Chin Tradit Herb Drugs</source><volume>47</volume><issue>19</issue><year>2016</year><fpage>3389</fpage><lpage>3394</lpage><comment>[in Chinese]</comment></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Salem</surname><given-names>M.L.</given-names></name><name><surname>Al-Khami</surname><given-names>A.A.</given-names></name><name><surname>El-Nagaar</surname><given-names>S.A.</given-names></name><name><surname>Zidan</surname><given-names>A.A.</given-names></name><name><surname>Al-Sharkawi</surname><given-names>I.M.</given-names></name><name><surname>Diaz-Montero</surname><given-names>C.M.</given-names></name><name><surname>Cole</surname><given-names>D.J.</given-names></name></person-group><article-title>Kinetics of rebounding of lymphoid and myeloid cells in mouse peripheral blood, spleen and bone marrow after treatment with cyclophosphamide</article-title><source>Cell Immunol</source><volume>276</volume><year>2012</year><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">22560674</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="book" id="sref17"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>J.</given-names></name><name><surname>Qing</surname><given-names>B.</given-names></name></person-group><chapter-title>Oncology and chemotherapy</chapter-title><year>2000</year><publisher-name>Henan Medical University Press</publisher-name><fpage>25</fpage><lpage>50</lpage><comment>[in Chinese]</comment></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Campisi</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name><name><surname>Lim</surname><given-names>C.S.</given-names></name><name><surname>Rubio</surname><given-names>M.</given-names></name></person-group><article-title>Cellular senescence, cancer and aging: the telomere connection</article-title><source>Exp Gerontol</source><volume>36</volume><year>2001</year><fpage>1619</fpage><lpage>1637</lpage><pub-id pub-id-type="pmid">11672984</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Marcotte</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>E.</given-names></name></person-group><article-title>Replicative senescence revisited</article-title><source>J&#x000a0;Gerontol A Biol Sci Med Sci</source><volume>57</volume><year>2002</year><fpage>257</fpage><lpage>269</lpage></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Dainiak</surname><given-names>N.</given-names></name></person-group><article-title>Hematologic consequences of exposure to ionizing radiation</article-title><source>Exp Hematol</source><volume>30</volume><issue>6</issue><year>2002</year><fpage>513</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">12063018</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Domen</surname><given-names>J.</given-names></name></person-group><article-title>The role of apoptosis in regulating hematopoiesis and hematopoietic stem cells</article-title><source>Immunol Res</source><volume>22</volume><issue>2&#x02013;3</issue><year>2000</year><fpage>83</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">11339368</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="book" id="sref22"><person-group person-group-type="author"><name><surname>Song</surname><given-names>M.</given-names></name><name><surname>Baik</surname><given-names>H.W.</given-names></name><name><surname>Hong</surname><given-names>S.G.</given-names></name><name><surname>Sung</surname><given-names>M.K.</given-names></name></person-group><series>Wheat bran arabinoxylan supplementationalleviates 5-fluorouracil induced mucositis andmyelosuppression in BALB/c Mice</series><volume>vol. 21</volume><year>2016</year><fpage>312</fpage><lpage>320</lpage></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group><article-title>Effect of Zishenshengxue capsule on myelosuppression in mice induced by</article-title><source>Cyclophosphamide</source><volume>33</volume><issue>2</issue><year>2013</year><fpage>233</fpage><lpage>237</lpage></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Carey</surname><given-names>P.J.</given-names></name></person-group><article-title>Drug-induced myelosuppression: diagnosis and management</article-title><source>Drug Safety</source><volume>26</volume><issue>10</issue><year>2003</year><fpage>691</fpage><lpage>706</lpage><pub-id pub-id-type="pmid">12862504</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Nakanishi</surname><given-names>T.</given-names></name></person-group><article-title>Effects of X-radiation and thymectomy on the immune response in the marine teleost Sebasticusmarmoratus</article-title><source>Dev Comp Immunol</source><volume>10</volume><issue>4</issue><year>1986</year><fpage>519</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">3817247</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Tatner</surname><given-names>M.F.</given-names></name></person-group><article-title>Natural changes in the immune system of fish</article-title><source>Fish Immune Syst Org Pathog Environ</source><year>1996</year><fpage>255</fpage><lpage>287</lpage></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Trede</surname><given-names>N.S.</given-names></name><name><surname>Zon</surname><given-names>L.I.</given-names></name></person-group><article-title>Development of T-cells during fish embryogenesis</article-title><source>Dev Compar Immunol</source><volume>22</volume><issue>3</issue><year>1998</year><fpage>253</fpage><lpage>263</lpage></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>J.F.</given-names></name><name><surname>Wang</surname><given-names>Y.M.</given-names></name><name><surname>Pang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Xue</surname><given-names>C.H.</given-names></name></person-group><article-title>Study of the radio-protective effect of cuttlefish ink on hemopoietic injury</article-title><source>Asia Pac J Clin Nutr</source><volume>16</volume><year>2007</year><fpage>239</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">17392111</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Queiroz</surname><given-names>M.L.</given-names></name><name><surname>Valadares</surname><given-names>M.C.</given-names></name><name><surname>Torello</surname><given-names>C.O.</given-names></name><name><surname>Ramos</surname><given-names>A.L.</given-names></name><name><surname>Oliveira</surname><given-names>A.B.</given-names></name><name><surname>Rocha</surname><given-names>F.D.</given-names></name><name><surname>Arruda</surname><given-names>V.A.</given-names></name><name><surname>Accorci</surname><given-names>W.R.</given-names></name></person-group><article-title>Comparative studies of the effects of Tabebuiaavellanedae bark extract and beta-lapachone on the hematopoietic response of tumour-bearing mice</article-title><source>J&#x000a0;Ethnopharmacol</source><volume>117</volume><issue>2</issue><year>2008</year><fpage>228</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">18343063</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>H.</given-names></name><name><surname>Geng</surname><given-names>X.</given-names></name><name><surname>Jia</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Zhi</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name></person-group><article-title>Studies on immune suppression on spleen cells of rats caused by cyclophosphamide</article-title><source>J&#x000a0;Toxicol</source><volume>28</volume><issue>3</issue><year>2014</year><fpage>189</fpage><lpage>194</lpage><comment>[in Chinese]</comment></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Probin</surname><given-names>V.</given-names></name><name><surname>Zhou</surname><given-names>D.</given-names></name></person-group><article-title>Cancer therapy-induced residual bone marrow injury-mechanisms of induction and implication for therapy</article-title><source>Curr Cancer Ther Rev</source><volume>2</volume><year>2006</year><fpage>271</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">19936034</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y.L.</given-names></name><name><surname>Wang</surname><given-names>L.Y.</given-names></name><name><surname>Wang</surname><given-names>J.X.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>C.L.</given-names></name><name><surname>Zhao</surname><given-names>D.P.</given-names></name><name><surname>Wang</surname><given-names>Z.C.</given-names></name><name><surname>Zhang</surname><given-names>J.J.</given-names></name></person-group><article-title>Protective effects of paeoniflorin and albiflorin on chemotherapy-induced myelosuppression in mice</article-title><source>Chin J Nat Med</source><volume>14</volume><issue>8</issue><year>2016</year><fpage>599</fpage><lpage>606</lpage><pub-id pub-id-type="pmid">27608949</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>T.</given-names></name><name><surname>Sakabe</surname><given-names>H.</given-names></name><name><surname>Tanimukai</surname><given-names>S.H.</given-names></name><name><surname>Abe</surname><given-names>T.</given-names></name><name><surname>Urata</surname><given-names>Y.</given-names></name><name><surname>Yasukawa</surname><given-names>K.</given-names></name><name><surname>Okano</surname><given-names>A.</given-names></name><name><surname>Taga</surname><given-names>T.</given-names></name><name><surname>Sugiyama</surname><given-names>H.</given-names></name><name><surname>Kishimoto</surname><given-names>T.</given-names></name></person-group><article-title>Simultaneous activation of signals through gp130, c-kit, andinterleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally actinglineage-specific factors</article-title><source>Blood</source><volume>90</volume><issue>12</issue><year>1997</year><fpage>4767</fpage><lpage>4778</lpage><pub-id pub-id-type="pmid">9389693</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Jaenisch</surname><given-names>R.</given-names></name><name><surname>Lodish</surname><given-names>H.F.</given-names></name></person-group><article-title>Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietinreceptor</article-title><source>Cell</source><volume>83</volume><issue>1</issue><year>1995</year><fpage>59</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">7553874</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.S.</given-names></name><name><surname>Lim</surname><given-names>S.K.</given-names></name><name><surname>DAgati</surname><given-names>V.</given-names></name><name><surname>Costantini</surname><given-names>F.</given-names></name></person-group><article-title>Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis</article-title><source>Genes Dev</source><volume>10</volume><issue>2</issue><year>1996</year><fpage>154</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">8566749</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Drachman</surname><given-names>J.G.</given-names></name></person-group><article-title>Role of thrombopoietin in hematopoietic stem cell and progenitor regulation</article-title><source>Curr Opin Hematol</source><volume>7</volume><issue>3</issue><year>2000</year><fpage>183</fpage><pub-id pub-id-type="pmid">10786657</pub-id></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Fujiwara</surname><given-names>T.</given-names></name><name><surname>Harigae</surname><given-names>H.</given-names></name><name><surname>Kameoka</surname><given-names>J.</given-names></name><name><surname>Yokoyama</surname><given-names>H.</given-names></name><name><surname>Takahashi</surname><given-names>S.</given-names></name><name><surname>Tomiya</surname><given-names>Y.</given-names></name><name><surname>Yamada</surname><given-names>M.</given-names></name><name><surname>Ishizawa</surname><given-names>K.</given-names></name><name><surname>Imaizumi</surname><given-names>M.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name></person-group><article-title>A&#x000a0;case of familial thrombocytosis: possible role of altered thrombopoietin production</article-title><source>Hematol</source><volume>76</volume><issue>4</issue><year>2004</year><fpage>395</fpage></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Ju</surname><given-names>G.Z.</given-names></name><name><surname>Ma</surname><given-names>S.M.</given-names></name><name><surname>Fu</surname><given-names>S.B.</given-names></name><name><surname>Liu</surname><given-names>S.Z.</given-names></name></person-group><article-title>The influence of radiation on mouse bone marrow cell cycle and its molecular mechanism</article-title><source>Chin J Radiol Med Protect</source><volume>22</volume><year>2002</year><fpage>342</fpage><lpage>343</lpage></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Kasid</surname><given-names>U.</given-names></name><name><surname>Suy</surname><given-names>S.</given-names></name><name><surname>Dent</surname><given-names>P.</given-names></name><name><surname>Whiteside</surname><given-names>T.L.</given-names></name></person-group><article-title>Activation of Raf by ionizing radiation</article-title><source>Nature</source><volume>382</volume><issue>6594</issue><year>1996</year><fpage>813</fpage><lpage>816</lpage><pub-id pub-id-type="pmid">8752275</pub-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Delia</surname><given-names>D.</given-names></name><name><surname>Aiello</surname><given-names>A.</given-names></name><name><surname>Soligo</surname><given-names>D.</given-names></name></person-group><article-title>Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells</article-title><source>Blood</source><volume>79</volume><issue>5</issue><year>1992</year><fpage>1291</fpage><lpage>1298</lpage><pub-id pub-id-type="pmid">1536952</pub-id></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y.</given-names></name></person-group><article-title>Mechanisms of caspase activation and inhibition during apoptosis</article-title><source>Cell Res</source><volume>12</volume><issue>3</issue><year>2002</year><fpage>459</fpage><lpage>470</lpage></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Cao</surname><given-names>D.M.</given-names></name><name><surname>Zhao</surname><given-names>X.X.</given-names></name></person-group><article-title>Study on dynamic effect of acupuncture on marrow cell cycle regulatory protein cyclin D1 expression and cell cycle in mice with cyclophosphamide induced myelosuppression</article-title><source>Chin J Integrated Tradit Western Med</source><volume>31</volume><issue>2</issue><year>2011</year><fpage>238</fpage><lpage>243</lpage></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Florentin</surname><given-names>A.</given-names></name><name><surname>Arama</surname><given-names>E.</given-names></name></person-group><article-title>Caspase levels and execution efficiencies determine the apoptotic potential of the cell</article-title><source>J&#x000a0;Cell Biol</source><volume>196</volume><issue>4</issue><year>2012</year><fpage>513</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">22351928</pub-id></element-citation></ref></ref-list><ack id="ack0010"><title>Acknowledgments</title><p>This work was financially supported by National key R&#x00026;D program, Key Technology Research of <funding-source id="gs1">Ginseng Industry and Development of Great Health Products</funding-source> (grant No. 2017YFC1702101).</p></ack></back></article>